Immediate Impact

76 standout
Sub-graph 1 of 21

Citing Papers

Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019
2023 Standout
2 intermediate papers

Works of M Cimarra being referenced

A double‐blind, placebo‐controlled study of immunotherapy with grass‐pollen extract Alutard SQ during a 3–year period with initial rush immunotherapy
1996
A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy
1996
and 1 more

Author Peers

Author Last Decade Papers Cites
M Cimarra 241 189 27 158 17 289
Esozia Arroabarren 200 171 35 97 21 293
S Ruffoni 163 176 11 67 15 269
B. Sáenz de San Pedro 201 81 59 106 15 303
Amedeo Piccolo 178 89 34 88 25 268
J. de Monchy 190 87 35 60 10 259
H. Chabane 219 86 82 102 23 271
Corrado Mirone 157 130 76 68 17 259
Luciana Mirotti 114 119 13 44 16 321
Elisabeth Pfrogner 238 245 10 53 17 332
S. Guez 124 125 7 74 25 226

All Works

Loading papers...

Rankless by CCL
2026